The SCOPE Summit has revealed the six finalists for its highly anticipated 2025 Participant Engagement Awards, celebrating excellence in innovation and impact within the clinical trial industry. This year’s announcement follows a competitive selection process that saw over 40 submissions, highlighting the evolving landscape of participant-centric initiatives.
The winners will be unveiled during the Monday afternoon keynote session at the SCOPE Summit, an event renowned for driving forward-thinking dialogue in clinical trials. For the full list of finalists and judges, visit Participant Engagement Award Finalists.
While the detailed list of finalists has not yet been made public, the judging panel—comprising experts in clinical research and patient engagement—evaluated each submission for its innovation, scalability, and measurable outcomes in fostering meaningful participant involvement.
As decentralized clinical trials (DCTs) and patient-centric approaches gain traction, these awards underscore the critical role of engagement strategies in improving clinical trial participation, retention, and diversity. With over 40 entries vying for the top spots, the finalists represent the best in addressing barriers to clinical trial access and enhancing participant experiences.
The winners will be celebrated at the SCOPE Summit keynote, setting the stage for broader industry discussions on how participant-focused innovations can redefine clinical research. Check out the full keynote agenda at SCOPE Keynotes.
Moe Alsumidaie is Chief Editor of The Clinical Trial Vanguard. Moe holds decades of experience in the clinical trials industry. Moe also serves as Head of Research at CliniBiz and Chief Data Scientist at Annex Clinical Corporation.
